The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in combination therapies.

Ono Pharmaceuticals has secured the global rights to sapablursen, an RNA-targeting therapy by Ionis to treat polycythemia ...

WuXi XDC Cayman has signed a memorandum of understanding (MoU) with South Korea-based AbTis to advance next-generation ADCs.

Vori Health has secured $53m in a Series B funding round, supporting its value-based musculoskeletal care offerings in the US ...

The specialist in temperature-sensitive pharmaceutical shipments, is introducing the industry’s most comprehensive cold chain ...

Entos Pharmaceuticals has announced an investment of C$62m ($43.05m) from the governments of Canada and Alberta for an R&D facility.

Europe’s drug regulatory agency has given Kizfizo a negative opinion for the second time, following one from November 2024.

MSD has opened a $1bn facility in Durham located in the US state of North Carolina, to increase vaccine manufacturing ...

The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial Supply Europe ...

Lundbeck has gained ODD from Japan’s Ministry of Health, Labor and Welfare (MHLW) for amlenetug to treat multiple system ...

Sun Pharmaceutical has agreed to acquire Checkpoint Therapeutics for an aggregate consideration of up to $355m upfront.

Kenox and Lactiga US have announced a strategic partnership for progressing new mucosal-targeted sIgA therapies development.